Related Experiment Video
Updated: Jun 26, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression
Jan Chemnitz1, Dorothea Pieper, Cordula Grüttner
1Heinrich-Pette-Institute for Experimental Virology and Immunology, Martinistrasse, Hamburg, Germany. jan.chemnitz@hpi.uni-hamburg.de
Insights
Casein kinase 2 (CK2) regulates CD83 expression by phosphorylating APRIL, a protein crucial for CD83 mRNA transport. Inhibiting CK2 blocks this transport, offering a new strategy to control CD83 levels in activated T cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD83 is a surface molecule vital for T-cell activation, expressed on mature dendritic cells (DCs) and activated T and B cells.
- CD83 mRNA nuclear-to-cytoplasmic transport involves HuR, CRM1, and the adaptor protein APRIL (ANP32B).
Purpose of the Study:
- To investigate the role of casein kinase 2 (CK2) in the regulation of CD83 mRNA nucleocytoplasmic translocation.
- To identify the specific site of APRIL phosphorylation by CK2 and its functional consequence on CD83 expression.
Main Methods:
- Utilized CK2-specific inhibitor (4,5,6,7-tetrabromo-2-azabenzimidazole) in activated Jurkat T cells.
- Performed depletion and knockdown studies targeting CK2 alpha and alpha' subunits.
- Assessed CD83 mRNA translocation and CD83 protein expression.
Main Results:
- CK2 phosphorylates APRIL at threonine244 (Thr(244)).
- CK2 inhibition disrupts CD83 mRNA nucleocytoplasmic translocation and reduces CD83 expression in T cells.
- The CK2 alpha' subunit is essential for this regulatory mechanism, while the alpha subunit is not.
Conclusions:
- CK2-mediated phosphorylation of APRIL is a key regulatory step in CD83 mRNA processing and transport.
- Targeting CK2 provides a novel strategy to modulate CD83 expression, impacting T-cell activation.
- This study elucidates a complex regulatory pathway for CD83 mRNA, enhancing understanding of immune cell function.
Abstract:
Fully mature DC and, to a lesser extent, activated T and B cells express CD83, a surface molecule that appears to fulfil an important role in efficient T-cell activation. Recently, it has been shown that CD83 mRNA is transported from the nucleus to the cytoplasm by an uncommon route, involving the cellular RNA-binding protein HuR and the nuclear export receptor CRM1. Moreover, the shuttle phosphoprotein APRIL (ANP32B) has been shown to be required for HuR-mediated nucleocytoplasmic translocation of the CD83 mRNA by acting as an adaptor that links HuR and CRM1. Here, we are able to report that casein kinase 2 (CK2) phosphorylates APRIL on residue threonine244 (Thr(244)) and demonstrate that the CK2-specific inhibitor 4,5,6,7-tetrabromo-2-azabenzimidazole abolishes CD83 expression in activated Jurkat T cells by interfering with the nucleocytoplasmic translocation of CD83 mRNA. Depletion and knockdown studies demonstrate that the CK2 alpha' subunit is necessary for this regulation, whereas the CK2 alpha subunit seems to be dispensable. Taken together, the data presented significantly extend our knowledge of the complex regulation of CD83 mRNA processing and provides a novel strategy to interfere with CD83 expression.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
IP3/DAG Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Second Messengers
The JAK-STAT Signaling Pathway
